Home/Filings/4/0001104659-24-107392
4//SEC Filing

Anderman Todd 4

Accession 0001104659-24-107392

CIK 0001393434other

Filed

Oct 8, 8:00 PM ET

Accepted

Oct 9, 5:32 PM ET

Size

7.6 KB

Accession

0001104659-24-107392

Insider Transaction Report

Form 4
Period: 2024-10-07
Anderman Todd
Chief Legal Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-10-07+296,500296,500 total
    Exercise: $9.48Exp: 2034-10-06Common Stock (296,500 underlying)
  • Award

    Common Stock

    2024-10-07+98,70098,700 total
Footnotes (2)
  • [F1]On October 7, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2019 Inducement Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal annual installments, beginning on the date of grant.
  • [F2]Vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the reporting person's first date of employment and 2.0833% of the shares vesting monthly thereafter.

Issuer

OCULAR THERAPEUTIX, INC

CIK 0001393434

Entity typeother

Related Parties

1
  • filerCIK 0002039533

Filing Metadata

Form type
4
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 5:32 PM ET
Size
7.6 KB